Abstract
Arsenic is one of the naturally occurring heavy metal that has been reported to cause damaging effects on different body organs. This study was aimed to determine the arsenic level in different water sources and investigate the effect of arsenic exposure on risk factors of diabetes mellitus (DM) in human participants and experimental animals. We recruited 150 participants to investigate the arsenic exposure in their urine and from drinking water. We found that males contained significantly higher (P < 0.001) concentrations of urinary arsenic as compared with that of their female counterparts. Similarly, urinary arsenic concentration was high and showed significant association in the age of ≥ 60 years (P < 0.05), illiterate (P < 0.001), smokers (P < 0.0001), and diabetic (P < 0.0001) participants. Moreover, urinary arsenic exposure was also associated with higher levels of fasting (P < 0.001) and random blood glucose (P < 0.001), HbA1c (P < 0.001), AST, ALT, MDA, IL-6, CRP, blood urea nitrogen, and creatinine in arsenic-exposed diabetics as compared with that of unexposed diabetics. Further, we also exposed the white albino rats with arsenic in drinking water for 30 days and their blood glucose was measured at 15th and 30th days of treatment that was significantly higher (P < 0.001) in arsenic-exposed animals as compared with that of unexposed animals. Similarly, arsenic-exposed animals failed to tolerate exogenously administered glucose (P < 0.001) as compared with that of unexposed animals. Likewise, insulin and glutathione concentrations were also significantly decreased (P < 0.001) in arsenic-exposed animals as compared with that of unexposed animals. The alterations in normal values of glucose, insulin, and glutathione exhibited the damaging effects of arsenic exposure in experimental rats. This study showed that arsenic exposed to human beings and animals through drinking water resulted in the disruption of pancreatic β-cell functioning that provoked the risk factor for development of DM. This study also suggested that long-term arsenic exposure induces hyperglycemia, inflammation, and oxidative stress that may lead to the onset of development of DM.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Aamir, A. H., Ul-Haq, Z., Mahar, S. A., Qureshi, F. M., Ahmad, I., Jawa, A., Sheikh, A., Raza, A., Fazid, S., & Jadoon, Z. (2019). Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ Open, 9, e025300.
Afridi, H. I., Kazi, T. G., Kazi, N., Jamali, M. K., Arain, M. B., Jalbani, N., Baig, J. A., & Sarfraz, R. A. (2008). Evaluation of status of toxic metals in biological samples of diabetes mellitus patients. Diabetes Research and Clinical Practice, 80, 280–288.
Akash, M. S. H., Rehman, K., & Chen, S. (2013). Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. Journal of Cellular Biochemistry, 114, 525–531.
Association AD. (2014). Diagnosis and classification of diabetes mellitus. Diabetes Care, 37, S81–S90.
Atsdr, U. (2007). Toxicological profile for arsenic. Agency for Toxic Substances and Disease Registry. Atlanta, GA: Division of Toxicology.
Bhardwaj, P., Jain, K., & Dhawan, D. K. (2018). Lithium treatment aggregates the adverse effects on erythrocytes subjected to arsenic exposure. Biological Trace Element Research, 184, 206–213.
Briggs, D. (2003). Environmental pollution and the global burden of disease. British Medical Bulletin, 68, 1–24.
Campbell, R. K. (2009). Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. Journal of the American Pharmacists Association, 49, S3–S9.
Castriota, F., Acevedo, J., Ferreccio, C., Smith, A. H., Liaw, J., Smith, M. T., & Steinmaus, C. (2018). Obesity and increased susceptibility to arsenic-related type 2 diabetes in Northern Chile. Environmental Research, 167, 248–254.
Chen, C.-J., Hsueh, Y.-M., Lai, M.-S., Shyu, M.-P., Chen, S.-Y., Wu, M.-M., Kuo, T.-L., & Tai, T.-Y. (1995). Increased prevalence of hypertension and long-term arsenic exposure. Hypertension, 25, 53–60.
Chen, Y., Ahsan, H., Slavkovich, V., Peltier, G. L., Gluskin, R. T., Parvez, F., Liu, X., & Graziano, J. H. (2010). No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environmental Health Perspectives, 118, 1299–1305.
Chen, Y., Graziano, J. H., Parvez, F., Liu, M., Slavkovich, V., Kalra, T., Argos, M., Islam, T., Ahmed, A., & Rakibuz-Zaman, M. (2011). Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ, 342, d2431.
Chen, Y., Wu, F., Liu, M., Parvez, F., Slavkovich, V., Eunus, M., Ahmed, A., Argos, M., Islam, T., & Rakibuz-Zaman, M. (2013). A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environmental Health Perspectives, 121, 832–838.
Douillet, C., Currier, J., Saunders, J., Bodnar, W. M., Matoušek, T. A., & Styblo, M. (2013). Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets. Toxicology and Applied Pharmacology, 267, 11–15.
Dover, E., Beck, R., Huang, M., Douillet, C., Wang, Z., Klett, E., & Stýblo, M. (2018). Arsenite and methylarsonite inhibit mitochondrial metabolism and glucose-stimulated insulin secretion in INS-1 832/13 β cells. Archives of Toxicology, 92, 693–704.
EPA. 2001. http://www.epa.gov/safewater/ars/arsenic_finalrule.html.
Frediani, J. K., Naioti, E. A., Vos, M. B., Figueroa, J., Marsit, C. J., & Welsh, J. A. (2018). Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among US adolescents and adults: an association modified by race/ethnicity, NHANES 2005–2014. Environmental Health, 17, 6.
Gribble, M. O., Howard, B. V., Umans, J. G., Shara, N. M., Francesconi, K. A., Goessler, W., Crainiceanu, C. M., Silbergeld, E. K., Guallar, E., & Navas-Acien, A. (2012). Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. American Journal of Epidemiology, 176, 865–874.
Hong, F., Jin, T., & Zhang, A. (2004). Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. Biometals, 17, 573–580.
Houston, M. C. (2011). Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. The Journal of Clinical Hypertension, 13, 621–627.
Hsu, L.-I., Hsieh, F.-I., Wang, Y.-H., Lai, T.-S., Wu, M.-M., Chen, C.-J., Chiou, H.-Y., & Hsu, K.-H. (2017). Arsenic exposure from drinking water and the incidence of CKD in low to moderate exposed areas of Taiwan: a 14-year prospective study. American Journal of Kidney Diseases, 70, 787–797.
Huang, C.-F., Yang, C.-Y., Chan, D.-C., Wang, C.-C., Huang, K.-H., Wu, C.-C., Tsai, K.-S., Yang, R.-S., & Liu, S.-H. (2015). Arsenic exposure and glucose intolerance/insulin resistance in estrogen-deficient female mice. Environmental Health Perspectives, 123, 1138–1144.
IARC A. (2012). Review of human carcinogens, part C: arsenic, metals, fibres, and dusts. IARC Monographs, Lyon, France, 100, 196–211.
Idrees, M., & Batool, S. (2018). Environmental risk assessment of chronic arsenic in drinking water and prevalence of type 2 diabetes mellitus in Pakistan. Environmental Technology, 1–18.
Izquierdo-Vega, J. A., Soto, C. A., Sanchez-Peña, L. C., De Vizcaya-Ruiz, A., & Del Razo, L. M. (2006). Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite. Toxicology Letters, 160, 135–142.
James, K. A., Marshall, J. A., Hokanson, J. E., Meliker, J. R., Zerbe, G. O., & Byers, T. E. (2013). A case-cohort study examining lifetime exposure to inorganic arsenic in drinking water and diabetes mellitus. Environmental Research, 123, 33–38.
Jomova, K., Jenisova, Z., Feszterova, M., Baros, S., Liska, J., Hudecova, D., Rhodes, C., & Valko, M. (2011). Arsenic: toxicity, oxidative stress and human disease. Journal of Applied Toxicology, 31, 95–107.
Kim, N. H., Mason, C. C., Nelson, R. G., Afton, S. E., Essader, A. S., Medlin, J. E., Levine, K. E., Hoppin, J. A., Lin, C., & Knowler, W. C. (2013). Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians. American Journal of Epidemiology, 177, 962–969.
Liu, S., Guo, X., Wu, B., Yu, H., Zhang, X., & Li, M. (2014). Arsenic induces diabetic effects through beta-cell dysfunction and increased gluconeogenesis in mice. Scientific Reports, 4, 6894.
Lobo, V., Patil, A., Phatak, A., & Chandra, N. (2010). Free radicals, antioxidants and functional foods: Impact on human health. Pharmacognosy Reviews, 4, 118.
Longnecker, M. P., & Daniels, J. L. (2001). Environmental contaminants as etiologic factors for diabetes. Environmental Health Perspectives, 109, 871.
Maiti, S., & Chatterjee, A. K. (2000). Differential response of cellular antioxidant mechanism of liver and kidney to arsenic exposure and its relation to dietary protein deficiency. Environmental Toxicology and Pharmacology, 8, 227–235.
Maiti, S., & Chatterjee, A. K. (2001). Effects on levels of glutathione and some related enzymes in tissues after an acute arsenic exposure in rats and their relationship to dietary protein deficiency. Archives of Toxicology, 75, 531–537.
Maull, E. A., Ahsan, H., Edwards, J., Longnecker, M. P., Navas-Acien, A., Pi, J., Silbergeld, E. K., Styblo, M., Tseng, C.-H., & Thayer, K. A. (2012). Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environmental Health Perspectives, 120, 1658–1670.
Milton, A. H., Smith, W., Rahman, B., Hasan, Z., Kulsum, U., Dear, K., Rakibuddin, M., & Ali, A. (2005). Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology, 16, 82–86.
Navas-Acien, A., Silbergeld, E. K., Streeter, R. A., Clark, J. M., Burke, T. A., & Guallar, E. (2006). Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiologic evidence. Environmental Health Perspectives, 114, 641–648.
Navas-Acien, A., Silbergeld, E. K., Pastor-Barriuso, R., & Guallar, E. (2008). Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA, 300, 814–822.
Nesha, M., Islam, M., Ferdous, N., Nazrul, F., Rasker, J. (2018). Chronic arsenic exposure through drinking water and risk of type 2 diabetes mellitus: a study from Bangladesh. J Family Med Prim Care Open Acc: JFOA-113.
Nordstrom, D. K. (2002). Worldwide occurrences of arsenic in ground watereditor^editors: American Association for the Advancement of Science.
Orloff, K., Mistry, K., & Metcalf, S. (2009). Biomonitoring for environmental exposures to arsenic. Journal of Toxicology and Environmental Health, Part B, 12, 509–524.
Paul, D. S., Walton, F. S., Saunders, R. J., & Stýblo, M. (2011). Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat diet. Environmental Health Perspectives, 119, 1104–1109.
Ravenscroft, P. (2007). Predicting the global distribution of natural arsenic contamination of groundwatereditor^editors. Symposium on arsenic: the geography of a global problem. London: Royal Geographical Society.
Rehman, K., & Akash, M. S. H. (2016). Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? Journal of Biomedical Science, 23, 87.
Rehman, K., & Akash, M. S. H. (2017). Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked? Journal of Cellular Biochemistry, 118, 3577–3585.
Rezaei, M., Khodayar, M. J., Seydi, E., Soheila, A., & Parsi, I. K. (2017). Acute, but not chronic, exposure to arsenic provokes glucose intolerance in rats: possible roles for oxidative stress and the adrenergic pathway. Canadian Journal of Diabetes, 41, 273–280.
Salazard, B., Bellon, L., Jean, S., Maraninchi, M., El-Yazidi, C., Orsiere, T., Margotat, A., Botta, A., & Bergé-Lefranc, J.-L. (2004). Low-level arsenite activates the transcription of genes involved in adipose differentiation. Cell Biology and Toxicology, 20, 375–385.
Santra, A., Maiti, A., Das, S., Lahiri, S., Charkaborty, S. K., Guha Mazumder, D. N., & Guha Mazumder, D. (2000). Hepatic damage caused by chronic arsenic toxicity in experimental animals. Journal of Toxicology. Clinical Toxicology, 38, 395–405.
Sasaki, A., Oshima, Y., & Fujimura, A. (2007). An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide. Experimental Hematology, 35, 252–262.
Shafik, N. M., & El Batsh, M. M. (2016). Protective effects of combined selenium and Punica granatum treatment on some inflammatory and oxidative stress markers in arsenic-induced hepatotoxicity in rats. Biological Trace Element Research, 169, 121–128.
Singh, M. K., Yadav, S. S., Yadav, R. S., Chauhan, A., Katiyar, D., & Khattri, S. (2015). Protective effect of Emblica-officinalis in arsenic induced biochemical alteration and inflammation in mice. Springerplus, 4, 438.
Tseng, C.-H., Tai, T.-Y., Chong, C.-K., Tseng, C.-P., Lai, M.-S., Lin, B. J., Chiou, H.-Y., Hsueh, Y.-M., Hsu, K.-H., & Chen, C.-J. (2000). Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environmental Health Perspectives, 108, 847–851.
Valko, M., Morris, H., & Cronin, M. (2005). Metals, toxicity and oxidative stress. Current Medicinal Chemistry, 12, 1161–1208.
von Ehrenstein, O. S., Poddar, S., Yuan, Y., Mazumder, D. G., Eskenazi, B., Basu, A., Hira-Smith, M., Ghosh, N., Lahiri, S., & Haque, R. (2007). Children’s intellectual function in relation to arsenic exposure. Epidemiology, 18, 44–51.
Wang, W., Xie, Z., Lin, Y., & Zhang, D. (2014a). Association of inorganic arsenic exposure with type 2 diabetes mellitus: a meta-analysis. Journal of Epidemiology and Community Health, 68, 176–184.
Wang, X., Zhao, H., Shao, Y., Wang, P., Wei, Y., Zhang, W., Jiang, J., Chen, Y., & Zhang, Z. (2014b). Nephroprotective effect of astaxanthin against trivalent inorganic arsenic-induced renal injury in wistar rats. Nutrition Research and Practice, 8, 46–53.
Wasserman, G. A., Liu, X., Parvez, F., Ahsan, H., Factor-Litvak, P., van Geen, A., Slavkovich, V., Lolacono, N. J., Cheng, Z., & Hussain, I. (2004). Water arsenic exposure and children’s intellectual function in Araihazar, Bangladesh. Environmental Health Perspectives, 112, 1329–1333.
Xia, X., Liang, C., Sheng, J., Yan, S., Huang, K., Li, Z., Pan, W., Tao, R., Hao, J., Zhu, B., Tong, S., & Tao, F. (2018). Association between serum arsenic levels and gestational diabetes mellitus: a population-based birth cohort study. Environmental Pollution, 235, 850–856.
Yuan, Y., Xiao, Y., Yu, Y., Liu, Y., Feng, W., Qiu, G., Wang, H., Liu, B., Wang, J., & Zhou, L. (2018). Associations of multiple plasma metals with incident type 2 diabetes in Chinese adults: the Dongfeng-Tongji Cohort. Environmental Pollution, 237, 917–925.
Funding
This study was financially supported by the Higher Education Commission (HEC) of Pakistan for (21-667/SRGP/R&D/HEC/2016 and 8365/Punjab/NRPU/R&D/HEC/2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rehman, K., Fatima, F. & Akash, M.S.H. Biochemical investigation of association of arsenic exposure with risk factors of diabetes mellitus in Pakistani population and its validation in animal model. Environ Monit Assess 191, 511 (2019). https://doi.org/10.1007/s10661-019-7670-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10661-019-7670-2